Michael Kulke
Impact in
-
- Cardiomyopathy and Myosin Studies
- Cardiovascular Function and Risk Factors
- Cardiovascular Effects of Exercise
- Cell Biology top 5%
- Cellular Mechanics and Interactions
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 14
-
- Multiple Myeloma Research and Treatments 7
- Co-authors
- Wolfgang A. LinkeCiprian NeagoeRoger J. HajjarFederica del MonteJudith K. GwathmeyJulio M. FernándezAve MinajevaChristiane A. Opitz
- Journals
- Cancer Research (15 papers)Blood (5 papers)Circulation Research (2 papers)European Journal of Cancer (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Michael Kulke
40 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 93
- Cardiology and Cardiovascular Medicine 898
- Cell Biology 261
- Molecular Biology 723
- Atomic and Molecular Physics, and Optics 324
- Oncology 234
Countries citing papers authored by Michael Kulke
This map shows the geographic impact of Michael Kulke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kulke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kulke more than expected).
Fields of papers citing papers by Michael Kulke
This network shows the impact of papers produced by Michael Kulke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kulke. The network helps show where Michael Kulke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Kulke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 11 | |
| 5 | 2021 | 26 | |
| 6 | 2021 | 1 | |
| 7 | 2020 | 61 | |
| 8 | 2019 | 1 | |
| 9 | 2018 | 11 | |
| 10 | 2017 | 11 | |
| 11 | Efficacy and Safety Results of Telotristat Ethyl in Patients With Carcinoid Syndrome During the Double-blind Treatment Period of the TELECAST Phase 3 Clinical Trial | 2017 | 5 |
| 12 | 2017 | 3 | |
| 13 | Patient Interviews in TELESTAR, a Phase 3 Study of Telotristat Etiprate, Report Meaningful Improvement in Carcinoid Syndrome | 2016 | 1 |
| 14 | 2014 | 11 | |
| 15 | 2013 | 58 | |
| 16 | PROGNOSTIC AND PREDICTIVE VALUE OF CHROMOGRANIN A AND NEURON-SPECIFIC ENOLASE IN PATIENTS (PTS) WITH ADVANCED PANCREATIC NEUROENDOCRINE TUMORS (PNET) TREATED WITH EVEROLIMUS | 2010 | 11 |
| 17 | 2002 | 160 | |
| 18 | 2002 | 31 | |
| 19 | 2001 | 173 | |
| 20 | 2000 | 4 |
About Michael Kulke
Michael Kulke is a scholar working on Radiology, Nuclear Medicine and Imaging, Hematology, Immunology, Neurology and Cardiology and Cardiovascular Medicine, having authored 44 papers that have together received 1.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (10 papers), Neuroendocrine Tumor Research Advances (9 papers), Cardiomyopathy and Myosin Studies (8 papers), Silymarin and Mushroom Poisoning (8 papers), Toxin Mechanisms and Immunotoxins (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Neuroblastoma Research and Treatments (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (898 citations), Cell Biology (261 citations), Molecular Biology (723 citations), Atomic and Molecular Physics, and Optics (324 citations) and Oncology (234 citations). Michael Kulke has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Wolfgang A. Linke, Ciprian Neagoe, Roger J. Hajjar, Federica del Monte, Judith K. Gwathmey, Julio M. Fernández, Ave Minajeva, Christiane A. Opitz, Mark C. Leake and Pieter P. de Tombe. Their work appears in journals such as Cancer Research, Blood, Circulation Research, European Journal of Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.